With this renewal, we will leverage human proteogenomics, engineered adipocyte depot models, and in vivo adipose-specific proteomics to discover and validate novel adipokines.
With this renewal, we will leverage human proteogenomics, engineered adipocyte depot models, and in vivo adipose-specific proteomics to discover and validate novel adipokines.